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Abstract. Optical coherence tomography (OCT) is a noninvasive imaging methodology that is able to image tissue
to depths of over 1 mm. Many epithelial conditions, such as melanoma and oral cancers, require an invasive
biopsy for diagnosis. A noninvasive, real-time, point of care method of imaging depth-resolved epithelial structure
could greatly improve early diagnosis and long-term monitoring in patients. Here, we have used tissue-engineered
(TE) models of normal skin and oral mucosa to generate models of melanoma and oral cancer. We have used these
to determine the ability of OCT to image epithelial differences in vitro. We report that while in vivo OCT gives
reasonable depth information for both skin and oral mucosa, in vitro the information provided is less detailed
but still useful. OCT can provide reassurance on the development of TE models of skin and oral mucosa as
they develop in vitro. OCT was able to detect the gross alteration in the epithelium of skin and mucosal models
generated with malignant cell lines but was less able to detect alteration in the epithelium of TE models that
mimicked oral dysplasia or, in models where tumor cells had penetrated into the dermis. C©2011 Society of Photo-Optical
Instrumentation Engineers (SPIE). [DOI: 10.1117/1.3652708]
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1 Introduction
Optical coherence tomography (OCT) is a noninvasive method
of imaging that utilizes the high penetration of long wavelength
light. OCT, often referred to as optical ultrasound, measures
backscattered and reflected light from different tissue structures
within a tissue sample. Differences in the optical properties and
reflectivity of tissue components create distinguishable signals
from different depths of the sample. OCT is currently and widely
used in ophthalmology as the optical properties of the eye make
it relatively easy to image compared to other tissues, which have
higher light scattering properties. It is hoped that the technical
advances that have allowed OCT to be increasingly used in
ophthalmology may extend to other areas of diagnostics and
imaging.
There is an increasing need for the development of method-
ologies for noninvasive imaging of tissues both for in vitro tis-
sue engineering purposes and clinically for disease diagnostics,
monitoring of tissue repair, and tissue reconstruction. We have
previously reported using swept-source OCT (SS-OCT) to mon-
itor re-epithelialization and wound healing in our reconstructed
skin constructs.1, 2
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OCT is increasingly being used to monitor the development
of oral cancer, oral mucositis, and basal cell carcinoma in the
papillary dermis in vivo.3–7 It is also being used to monitor
the development of tissue-engineered (TE) models or oral mu-
cosa and to noninvasively monitor skin. For example, Boppart
et al.8–10 used an Nd:YVO4-pumped Ti-Saph laser with a res-
olution of 10 μm to monitor the in vitro migration of murine
macrophages through a matrigel matrix; while others have used
OCT to monitor the development of TE skin composed of epi-
dermal keratinocytes on top of a fibroblast-populated amorphous
collagen gel.11, 12
Previous work from our laboratory has shown that OCT can
effectively monitor the development of an epithelium in a TE
skin model based on human dermis1 and can also be used to
monitor wound healing in this model.2 We suggest that the three-
dimensional (3D) models we have developed13 provide excellent
test-beds in which to explore the limits of discrimination of OCT
for tumor cells.
The aim of this study was to assess the ability of OCT to detect
epithelial disruption due to the presence of metastatic melanoma
and early invasive oral cancer in 3D tissue-engineered constructs
in vitro. To this end, we compared OCT and histological images
from skin and mucosal models generated with carcinoma and
dysplastic cell lines to those generated with normal oral or skin
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keratinocytes, and as a reference, we compared these images to
those of skin and oral mucosa from a normal healthy volunteer.
2 Materials and Methods
2.1 Primary Cell Culture
Skin keratinocytes and human skin dermal fibroblasts were har-
vested from split thickness skin grafts (STSGs) obtained from
specimens following routine breast reductions and abdomino-
plasties (Ethical Committee of the Northern General Hospi-
tal Trust, Sheffield, United Kingdom, Ref: 06/Q2306/25). Oral
keratinocytes and oral fibroblasts were extracted from buccal
tissue obtained from consenting patients during routine dental
surgeries [Sheffield Research Ethics Committee approval (Ref:
07/H1309/105)]. Cell extraction was performed as previously
described in Refs. 13 and 14.
Skin and oral keratinocytes were grown in Green’s medium
consisting of Dulbecco’s modified eagles medium (DMEM) and
Ham’s F12 medium in a 3:1 ratio supplemented with 10% (v/v)
foetal calf serum (FCS), 100 IU/ml penicillin, 100 μg/ml strep-
tomycin, 0.625 μg/ml amphotericin B, 6.25 μg/ml adenine,
10 ng/ml epidermal growth factor, 1.36 ng/ml triidothyronine,
5 μg/ml transferrin, 5 μg/ml insulin, 0.4 μg/ml hydrocorti-
sone, and 8.5 ng/ml cholera toxin. Dermal and oral fibroblasts
were grown in fibroblast culture medium (FCM) consisting of
DMEM supplemented with 10% (v/v) foetal calf serum (FCS),
100 IU/ml penicillin, 100 μg/ml streptomycin, and 0.625 μg/ml
amphotericin B. All reagents were purchased from Sigma-
Aldrich, United Kingdom, except FCS, which was purchased
from Biowest Biosera, United Kingdom. All cells were cultured
at 37◦C in a 5% CO2/95% air humidified incubator. Passage 1
to 3 keratinocytes and passage 4 to 9 fibroblasts were used in all
experiments.
2.2 Human Melanoma Cell Culture
Three human metastatic melanoma cell lines were used, HBL,
A375-SM, and C8161. The HBL cell line was derived from a
lymph node metastasis of a nodular melanoma. Cells were main-
tained in Ham’s F10 medium supplemented with 5% (v/v) FCS,
5% (v/v) newborn calf serum, 2 mM L-glutamine, 100 IU/ml
penicillin, plus 100 μg/ml streptomycin. The A375-SM cell line
was a kind gift from Professor M. J. Humphries (University of
Manchester, United Kingdom). The A375 cell line was estab-
lished in culture from a lymph node metastasis of a 54-year-old
female. The C8161 cell line was derived from an abdominal wall
metastasis from a post-menopausal woman with recurrent ma-
lignant melanoma and was donated by M. Edwards (University
of Glasgow, United Kingdom). Both A375-SM and C8161 cells
were cultured in Eagle’s modified essential media supplemented
with 10% (v/v) FCS, 2 mM L-glutamine, 100 IU/ml penicillin,
100 μg/ml streptomycin, 1.2 μg/ml amphotericin B, 1.5% (v/v)
(100 × stock) vitamin concentrate, 1 mM sodium pyruvate, and
10% (v/v) nonessential amino acids.
2.3 Oral Cancer Cell Lines
The D20 dysplastic cell line was kindly donated by Dr. Keith
Hunter (University of Sheffield, United Kingdom).15, 16 D20
cells were cultured in Green’s medium (as previously described
for keratinocytes). The SCC9 cell line was originally isolated
from the tongue of a patient with squamous cell carcinoma
(SCC) and cultured in a 1:1 ratio of DMEM: Ham’s F12, sup-
plemented with 10% FCS, 0.4 μg/ml hydrocortisone, 100 IU/ml
penicillin, 100 μg/ml streptomycin, and 0.625 μg/ml ampho-
tericin B. Cal27 is a squamous cell carcinoma human cell line
isolated from the tongue of a patient with squamous cell carci-
noma (ATCC, Manassas, Virginia).
2.4 Production of TE Models
STSGs were obtained during routine plastic surgery breast re-
duction and abdominoplasty operations or obtained from the
Euro-Skin Bank (Netherlands). Glycerol was removed from
Euro-Skin by extensive washing in phosphate buffered saline
(PBS) and then both the STSG and Euro-Skin were immersed
in sterile 1 M sodium chloride for 18 h at 37◦C, resulting in an
acellular de-epidermized human dermis (DED). The DED was
thoroughly washed with PBS and placed into FCM. The DED
was cut into squares approximately 2 × 2 cm and the papillary
surface was orientated uppermost in Corning Costar 3516 6-well
plates (Corning Inc., United Kingdom). Tissue-engineered skin
and oral mucosa models were produced using a modified version
of the method of Chakrabarty et al.17 In brief, 1 × 105 dermal
or 5 × 105 oral fibroblasts and 1 × 106 epithelial or 5 × 105
oral keratinocytes were seeded in Green’s media into a medical
stainless steel ring placed onto the papillary surface of the DED.
After 48 h in submerged culture, the constructs were raised to
an air-liquid interface and cultured in Green’s medium for up to
22 days. For models containing melanoma cells in addition to
the 1 × 106 keratinocytes, 5 × 105 melanoma cells were also
added to the models. For models of oral carcinoma, 2.5 × 105
oral cancer cells were added to the model instead of 5 × 105
oral keratinocytes.
Media changes were performed every three to four days, or
more frequently if the media was visibly depleted, indicated by a
color change from red-purple to orange-yellow. For routine his-
tology, constructs were transferred to 10% phosphate-buffered
formaldehyde at room temperature. Samples were processed,
embedded in paraffin wax, sectioned to a thickness of 4 μm,
mounted, and stained using haematoxylin and eosin (H&E).
2.5 OCT Imaging of TE Models
Imaging of all of the TE models was performed using a SS-OCT
system that is based on a Michelson Diagnostics Ltd. swept-
source OCT data acquisition system (Michelson Diagnostics,
Kent, United Kingdom) coupled to a Thorlabs LSM03 scan lens
and in-house fiber interferometer (Thorlabs, Cambridgeshire,
United Kingdom) with the models maintained in their standard
six-well tissue culture plastic dishes. Imaging was performed
through the tissue culture plastic lid to keep the TE models
sterile and viable. The SS-OCT system was a Fourier domain
OCT device, meaning that the images could be taken faster than
with traditional time domain OCT. The light source was a Santec
HSL-2000-10 wide sweep-laser with a wavelength of 1305 nm
± 15 nm with a sweep range of 150 nm. The OCT system uses an
imaging engine (light source, detectors, PC/DAQ and software)
adapted from a Michelson Diagnostics Ltd. EX1301 system. The
interferometer and sample arm optics are built in-house using
an SMF-28 beam splitter and circulator and a Thorlabs OCT
Journal of Biomedical Optics November 2011  Vol. 16(11)116015-2
Downloaded from SPIE Digital Library on 31 Oct 2011 to 130.220.71.21. Terms of Use:  http://spiedl.org/terms
Smith et al.: Evaluating the use of optical coherence tomography...
Fig. 1 Representative SS-OCT images of reconstructed skin developing over 22 days. HBL melanoma, A375-SM, and C8161 melanoma cells were
also added to the reconstructed skin. Changes to the epidermis can be seen from day 8 onward when the HBL and A375-SM cells are in the
reconstructed skin. There do not appear to be any differences when the C8161 cells are added.
objective and galvo scanners. The lateral resolution, in the plane
of best focus, of the OCT system is defined by the Thorlabs
LSM03 objective in the sample arm. In air, we measured a
modulation depth of 45% using Element 1 of Group 5 in the
USAF 1951 test target. For a Gaussian beam, this implies a
full width half maximum (FWHM) spot size of around 15 μm.
With the culture dish lid inserted, the modulation fell to 30%,
implying a degradation of the FWHM spot size to 18 μm. This is
most likely due to spherical and higher-order beam aberrations.
The axial point spread function FWHM in air was measured to
be 6.4 μm, degrading to 7.5 μm with the lid inserted. Mostly,
this was due to uncompensated optical dispersion as it could be
restored to 6.7 μm by inserting a matching lid into the reference
arm (however, this was not done for these experiments). The
overall dynamic range of this system was measured at 94 dB
using a 10-kHz A-scan rate. The tissue culture plastic lids were
left in place to ensure sterility of these experiments and also
gently heated to remove any condensation before imaging and
as required during imaging. Three TE models of each type were
imaged in multiple sites toward the middle of the models. Only
representative images are shown.
3 Results
3.1 Ability of OCT to Detect Changes in
Reconstructed Skin Due to the Presence of
Melanoma
Figure 1 shows representative SS-OCT images of the TE skin as
it develops over 22 days after being raised to an air-liquid inter-
face. The upper panel shows the controlled TE skin throughout
22 days of culture. The three lower panels show experiments
in which melanoma cells were added, imaging the constructs at
days 1, 8, 15, and 22. HBL cells are minimally invasive cells and
as seen in Fig. 1 appear to cause minor changes to the structure
of the epidermis. The A375-SM cells are moderately invasive
and appear to cause a marked amount of disruption to the epi-
dermis. The C8161 cells are highly invasive but in Fig. 1 do not
appear to affect the reconstructed skin.
Figure 2 compares the images obtained from reconstructed
skin with and without melanoma after 22 days of culture to the
accompanying H&E histology. In the controlled reconstructed
skin, the SS-OCT [Fig. 2(a)] and histology images [Fig. 2(b)]
both show a progressively differentiated epidermis that is at-
tached to the underlying dermis. This also appears to be the case
when the HBL cells are added to the reconstructed skin model.
When A375-SM cells are added to the reconstructed skin model,
there are significant changes to the SS-OCT image [Fig. 2(e)]
and these are mirrored in the histology [Fig. 2(f)]. There is an
additional darker, less scattered layer above the epidermis. The
histology suggests that these are lightly attached melanoma cells
that have not entered the epidermis. Moving on to C8161 cells,
these are highly metastatic and invade into the papillary dermis
[as can be seen in the inset to Fig. 2(g)] that cannot be seen
in the OCT image [Fig. 2(g)].18, 19 This invasion of melanoma
cells into the dermis does not cause any visible disruption of the
epidermal layer.
3.2 Ability of OCT to Detect Changes in
Reconstructed Oral Epithelia Due to the
Presence of Oral Squamous Cell Carcinoma
Cell Lines
Figure 3 shows the appearance of three oral squamous cell car-
cinoma (OSCC) models and our TE oral mucosa when imaged
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Fig. 2 (a) Representative SS-OCT image of reconstructed skin and (b) accompanying histology. (c) Representative SS-OCT image of reconstructed
skin + HBL melanoma cells and (d) accompanying histology. (e) Representative SS-OCT image of reconstructed skin + A375-SM melanoma cells
and (f) accompanying histology. (g) Representative SS-OCT image of reconstructed skin + C8161 melanoma cells and (h) accompanying histology.
All images were taken after the models had been at an air-liquid interface for 22 days. All histology stained with H&E. Scale bar = 1 mm.
using OCT and traditional histological methods. Figure 3(a)
shows a complete epithelium that is confirmed in the accompa-
nying histology [Fig. 3(b)]. In all four OCT images, the epithe-
lium can be distinguished from the connective tissue compo-
nent as there is a difference in brightness due to an increase
in backscattered light (with the connective tissue appearing
brighter). This gives information about the thickness of the ep-
ithelium, which is often altered in pre-cancerous lesions (dys-
plasia). More subtle features and individual cells within the
epithelia could not be distinguished using OCT. In Fig. 3(c),
variations in the levels of brightness can be seen in the epithe-
lium. This could potentially be explained by the accompanying
histology [Fig. 3(d)], where islands of terminally differentiated
cells are surrounded by highly proliferative cells. In Fig. 3(e),
the epithelium in the OCT images is too thin to make out much
detail, however, there does appear to be some variation in the
brightness of the epithelium. This may again be explained by
the islands of terminally differentiated cells in the accompany-
ing histology [Fig. 3(f)]. In Fig. 3(h), the model cultured from
Cal27 cells had a very distinct appearance with the epithelium
appearing in two layers. The most superficial of these layers was
highly keratinized with an irregular surface topology that split on
sectioning from a lower layer of more proliferative-looking/less-
differentiated epithelial cells. This two-layer epithelium and
the irregular surface topology is just visible in Fig. 3(g) with
the two layers of the epithelium showing slightly different
brightness intensities; again, the less-differentiated cells ap-
pearing darker (less backscattering) than the more-differentiated
cells.
3.3 Ability of OCT to Image Skin and Oral Mucosa
In Vivo
Figure 4 shows OCT images of a human fingertip [Fig. 4(a)] and
the mucosal surface of the lower lip [Fig. 4(c)] obtained in vivo
from a healthy volunteer, along with corresponding histology of
human skin [Fig. 4(b)] and oral mucosa [Fig. 4(d)]. This was im-
aged using the SS-OCT system. In these images, features within
the connective tissues can be distinguished including blood ves-
sels and minor sweat and salivary glands. These features were
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Fig. 3 (a) Representative SS-OCT image of TE oral mucosa and (b) accompanying histology. (c) Representative SS-OCT image of D20 model of
invasive carcinoma and (d) accompanying histology. (e) Representative SS-OCT image of SCC9 model of severe dysplasia and (f) accompanying
histology. (g) Representative SS-OCT image of Cal27 model of invasive carcinoma and (h) accompanying histology. All images were taken after the
models had been at an air-liquid interface for 14 days. All histology stained with H&E. Scale bar = 1 mm.
more clearly imaged in the lip than in the skin. The OCT was
able to obtain information over 500 μm deep in both the oral
mucosa and skin, highlighting its potential to clinically diagnose
both epithelial disorders, such as OSCC and SCC, but also sub-
mucosal conditions such as Sjögren’s syndrome, which affects
the salivary glands.
4 Discussion
Optical coherence tomography is a well-established technique
for cross-sectional imaging of tissue, which is very successful in
ophthalmology, but in areas such as dermatology, there are still
challenges ahead.20 We have previously shown that OCT can be
successfully used to image TE skin1, 2, 21 and we have also com-
pared the imaging capabilities of OCT with other laboratory-
based imaging techniques.22 We have shown that OCT can be
used to give experimental assurance about the development of
TE skin, which is particularly valuable in experiments that may
last for up to a month. However, we have not, until now, looked
at whether OCT can be used to discriminate between normal
and abnormal epithelia. In this study, we compared the ability
of OCT to detect invasion of melanoma and OSCC in 3D mod-
els of TE skin and oral mucosa, respectively. Clearly, the ability
of OCT to generate useful noninvasive information to detect
epithelial abnormalities would be invaluable as many studies
attest.4, 6, 23–25 However, at present, the level of discrimination
obtained with OCT in skin and oral mucosa remains close to
being useful but falls short of something that could be routinely
used for this purpose in vitro or in vivo.
Three-dimensional TE skin models constructed of cancer
cell lines are useful experimental models in which to assess cur-
rent OCT systems and also develop improvements to them. The
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Fig. 4 (a) SS-OCT image of the skin of the finger tip in vivo. (b) Example histology of human skin. (c) SS-OCT image of the lower lip imaged in vivo.
(d) Example histology of human oral mucosa. All histology stained with H&E. Scale bar = 1 mm.
three metastatic melanoma cell lines used in this study were
HBL, A375-SM, and C8161 cell lines. Previous work in our
group has shown that these cells have different invasive capa-
bilities when cultured in three dimensions with human dermal
fibroblasts and keratinocytes.18, 19 Of the three melanoma cell
types, the HBL cells are minimally invasive, the A375-SM cells
moderately invasive, and the C8161 cells highly invasive. For
TE oral mucosa, again, three different oral cell lines were used,
D20 a dysplastic cell line, and SCC9 and Cal27 both oral squa-
mous cell carcinoma cell lines. When cultured in 3D, the D20
cells produce an epithelium that resembles a severe oral dyspla-
sia (often a pre-cursor to oral cancer), while the SCC9 and Cal27
cell lines produce models resembling squamous cell carcinoma
and become invasive when cultured longer.26 The main finding
of this study was that where there were gross disruptions to the
epithelia of skin and oral models by the presence of cancer cells
these were visible in the OCT images. These disruptions were
comparable to disruptions seen with histological examination
of tissue sections obtained from these samples. OCT did not,
however, provide adequate resolution to discriminate between
alterations in the epithelium caused by cancer cells compared
to normal TE epithelium. The level of discrimination that we
obtained was slightly better in the oral TE samples than in the
skin TE samples, perhaps giving a clue to some of the problems
that must be overcome.
Skin is not an ideal optical medium. It is optically complex,
variable, and multilayered, which poses many problems to
imaging.24 It was evident that the images of skin in vivo on a fin-
gertip were clearer than the images obtained from the in vitro TE
model. It has been previously noticed that ex vivo and in vitro
samples do not give as clear OCT images compared to in vivo
images.21 Hsiung et al. looked at the image quality degradation
over time post-excision and found a reduction in signal intensity
within a matter of hours. This was attributed to a loss of
blood-flow, cell lysis, and subsequent changes in the tissue’s
microstructure.27 It has been suggested that where keratin is
packed tightly, such as in the fingertip stratum corneum, the
OCT image would be expected to be less intense/less scattering,
due to lack of changes in the index of refraction. However, in
the TE constructs where the keratin is looser and mixed with
cellular regions, air, or media, the keratinized regions might
be expected to be more intense/more scattering. This appears
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to occur in the OCT images in Figs. 1 and 2. For clinical
applications, image degradation post excision is not a problem
as real-time, noninvasive imaging is the ultimate aim. However,
this may explain the difference in image quality obtained from
TE models compared to in vivo tissue. Further clinical studies
need to be undertaken to study, in more detail, the different
appearances that arise from OCT imaging of different stages
of OSCC and other potentially malignant mucosal conditions,
as well as testing the specificities and sensitivities that can be
achieved. OCT devices are still a relatively new technology and,
for the most part, have been optimized for ocular applications.
OCT development directed for oral or skin applications may
further improve the images that can be obtained.
The ability of OCT to image differences in TE models of
OSCC was also evaluated in this study. Tissue-engineered mod-
els such as these were able to give clear images of some features
of the epithelium, such as the boundary of epithelium and con-
nective tissue. Images taken in vivo, again appeared clearer and
more features (many of which were not present in TE models)
were visible, for example blood vessels.
Pathologically, the appearance of the epithelial connective
tissue junction is important when diagnosing a number of dif-
ferent conditions, not just OSCC. Many mucosal diseases, in-
cluding lichen planus, affect the junction between the epithelium
and connective tissue and the diagnosis of these conditions may
also benefit from OCT investigation. The ability to visualize
not just the epithelium but also the adjacent connective tissue
including blood vessels, ducts, and minor salivary glands may
mean OCT has potential for diagnosis of nonmalignant oral dis-
eases such as oral ulcerative conditions, Sjögren’s syndrome,
vascular anomolier, superficial cystic lesions, submucous fibro-
sis, orafacial granulomatosis, and lichen planus.
OCT is already being used to clinically examine oral28 and
laryngeal29 lesions. Studies have shown good sensitivity and
specificity when detecting carcinoma in situ and OSCC.30, 31
Images of dysplastic lesions showed epithelial thickening, loss
of epithelial stratification, and epithelial down-growth as com-
pared with healthy oral mucosa. Areas of OSCC were identified
by the absence or disruption of the basement membrane, an ep-
ithelial layer that was highly variable in thickness, with areas of
erosion and extensive epithelial down-growth and invasion into
the sub-epithelial layers.32 It was noted by Tsai et al. that when
the neoplasm can be classified as mild or moderate dysplasia,
there is a clear boundary between the epithelium and connective
tissue, which disappears upon development of OSCC.31 This
was also the case when imaging nondysplastic lesions of the lar-
ynx, epithelial thickening with a defined basement membrane
for benign lesions, and a loss of basement integrity with the
development of laryngeal cancer.29
Given these findings, it is hoped that OCT may help to define
surgical margins, reduce the need for investigative biopsies, and
provide direct evaluation of the effectiveness of cancer treat-
ments in the future.28 OCT might also be used to image the
whole oral cavity of a patient with a malignant lesion and find
other areas of malignancy in the oral cavity that may not be
observed by the naked eye. OCT could also be used by the
clinician to monitor areas of dysplasia, which could help in
the long term management of oral lesions and may avoid the
necessity for regular repeat biopsy of these lesions.33 Another
major advantage over biopsy is the ability to produce real-time,
point of care images of the tissues that can be discussed with
the patient and enable efficient treatment planning and decision
making without the need for a repeat visit as is needed following
a biopsy.
In conclusion, OCT has the potential be a valuable tool in
detecting epithelial abnormalities and, here, we demonstrate that
it can detect major disruptions to the epithelial layer in both TE
skin and oral mucosa. However, the system as used at present
lacks the ability to detect more subtle perturbations or to detect
cancer cells within the underlying connective tissue. However,
this study does provide experimental models that can be used
in future optimization studies to improve the resolution of the
OCT systems currently available.
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